1 Min Read
FRANKFURT, July 13 (Reuters) - Gerresheimer already has firm orders for 80 percent of what it expects to make in second-half sales in its U.S. glass business, Chief Executive Uwe Roehrhoff told reporters on Thursday, reiterating his optimism about the end of the year.
The German drugs-packaging firm earlier reported lower second-quarter sales and earnings, partly due to U.S. customer uncertainty over healthcare policy, but said it expected a rebound in the fourth quarter.
Roehrhoff also said he expected shortly to be able to fill a gap in Gerresheimer's portfolio by acquiring syringe-security technology that would protect needles, which is a regulatory requirement in many regions. (Reporting by Georgina Prodhan; Editing by Maria Sheahan)